Funding · Company
FORE US Bio Inc.
Philadelphia, PABiotech & Pharma
FORE US Bio Inc. of Philadelphia, PA has disclosed $132M across 2 Form D offerings filed with the SEC between Aug 24, 2023 and Jul 14, 2026.
$132M
Total disclosed
2
Form D offerings
2022
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$70M
Form D · Jul 14, 2026 ↗
Q3 2026
· 1 amendment, first filed May 15, 2025
· target $110M
$62M
Form D · Aug 24, 2023 ↗
Q3 2023
· target $123M
Filing details
HeadquartersPhiladelphia, PAIndustryBiotech & Pharma (Biotechnology)Incorporated2022SEC CIK0001990659Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →